A recent analysis has revealed wide variations in cancer screening practices across Europe, with no country scoring perfectly on all fronts. The European Union aims to have 90% of eligible individuals screened for breast, cervical, or colorectal cancer by 2025, but the likelihood of getting tested largely depends on where one lives.
The European Cancer Organisation’s report highlighted that countries like Slovenia, Portugal, and Norway are more aligned with EU guidelines on cancer screening, while Bulgaria, Romania, and Greece lag behind. The analysis considered factors like screening rates, recommended time intervals between screenings, national coverage, and types of screening tests used to assign an overall policy score to each country.
Despite disparities, few countries fully implement all of the EU’s recommended screening practices in their national cancer programmes. The most common cancer diagnoses in the EU include breast, colorectal, prostate, and lung cancers, urging the need for effective screening programs targeting these diseases.
Furthermore, the analysis also revealed major disparities within countries, taking into account factors like education, income, and urban-rural status. Denmark, for example, a country that performs well on the index, primarily detects cancer cases outside of screening programs.
While screening plays a significant role in early detection, it is not the sole tool for catching cancer cases, as highlighted by the low percentage of cases caught through screening in Denmark. This underscores the importance of overall cancer awareness and access to medical care in ensuring timely diagnosis and treatment for individuals across Europe.
Source
Photo credit www.euronews.com
